ARTICLE | Clinical News
AC-1204: Completed Phase III enrollment
May 23, 2016 7:00 AM UTC
Accera completed enrollment of >400 patients with mild to moderate AD in the double-blind, placebo-controlled, U.S. Phase III NOURISH AD trial evaluating once-daily oral AC-1204 for 26 weeks. NOURISH ...